Speakers

Early confirmed speakers include

 

Ana Filipa Alexandre, Vice President, Head of Pricing and Market Access, Santen

Ana Filipa Alexandre | Vice President, Head of Pricing and Market Access | Santen » speaking at World EPA Congress

Amer Al-Taie, Senior Director, Value & Evidence Team Lead, Pfizer

Amer Al-Taie | Senior Director, Value & Evidence Team Lead | Pfizer » speaking at World EPA Congress

Luigi Angelillo, Director, Market Access EMEA, Argenx

Luigi Angelillo | Director, Market Access EMEA | Argenx » speaking at World EPA Congress

Ad Antonisse, Director, Market Access & External Affairs, AstraZeneca

Ad Antonisse | Director, Market Access & External Affairs | AstraZeneca » speaking at World EPA Congress

Diego Ardigò, Global Rare Disease, Research & Development Head & Executive Board Member and Vice Chair, Chiesi Group & EUCOPE

Diego Ardigò | Global Rare Disease, Research & Development Head & Executive Board Member and Vice Chair | Chiesi Group & EUCOPE » speaking at World EPA Congress

Marnix Artz, Head Patient Access, Pricing & Governmental Affairs, Merck Group

Marnix Artz | Head Patient Access, Pricing & Governmental Affairs | Merck Group » speaking at World EPA Congress

Mr Johnny Bane, Head of Market Access, Accord Healthcare

Mr Johnny Bane | Head of Market Access | Accord Healthcare » speaking at World EPA Congress

Alexander Bastian, Vice President, Value & Market Access, A.M. Pharma

Alexander Bastian | Vice President, Value & Market Access | A.M. Pharma » speaking at World EPA Congress

Bjørn Bayer, Director, Therapeutic Area CVMRPH, Janssen

Bjørn Bayer | Director, Therapeutic Area CVMRPH | Janssen » speaking at World EPA Congress

Tomer Ben Zaken, Director, Head of Sick Funds & Hospitals Access, Abbvie

Tomer Ben Zaken | Director, Head of Sick Funds & Hospitals Access | Abbvie » speaking at World EPA Congress

Katja Berg, Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU, AstraZeneca

Katja Berg | Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU | AstraZeneca » speaking at World EPA Congress

Nick Besseling, Manager, Value Strategies & Agreements, AstraZeneca

Nick Besseling | Manager, Value Strategies & Agreements | AstraZeneca » speaking at World EPA Congress

Chris Bidad, Global Head, Access Strategy and Payer Policy, AstraZeneca

Chris Bidad | Global Head, Access Strategy and Payer Policy | AstraZeneca » speaking at World EPA Congress

Jesper Bjerggren, Associate Director, European Market Access, Teva Pharmaceuticals

Jesper Bjerggren | Associate Director, European Market Access | Teva Pharmaceuticals » speaking at World EPA Congress

Marie-Sharmila Blandino, Director, Global Access Strategy Lead, Amgen

Marie-Sharmila Blandino | Director, Global Access Strategy Lead | Amgen » speaking at World EPA Congress

Par Bolina, Adjunct Associate Professor, Medicinal Chemistry, Rutgers University

Par Bolina | Adjunct Associate Professor, Medicinal Chemistry | Rutgers University » speaking at World EPA Congress

Thomas Bols, Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics

Thomas Bols | Head of Government Affairs and Patient Advocacy, EMEA | PTC Therapeutics » speaking at World EPA Congress

Anh Bourcet, External Advisor, Market Access Lead, APACMed, Asia Pacific Medical Technology Association

Anh Bourcet | External Advisor, Market Access Lead | APACMed, Asia Pacific Medical Technology Association » speaking at World EPA Congress

Vidya Breeveld, Independent Market Access Expert

Vidya Breeveld |  | Independent Market Access Expert » speaking at World EPA Congress

Charles Brown, Director, Global Pricing & Contracting, Novartis

Charles Brown | Director, Global Pricing & Contracting | Novartis » speaking at World EPA Congress

Robert Burley, Director, Care, Campaigns and Support, The Muscular Dystrophy U.K.

Robert Burley | Director, Care, Campaigns and Support | The Muscular Dystrophy U.K. » speaking at World EPA Congress

Astrid Buys, Director, Global Head of Tenders and Pricing, Bavarian Nordic A/S

Astrid Buys | Director, Global Head of Tenders and Pricing | Bavarian Nordic A/S » speaking at World EPA Congress

Lorenzo Capretto, Market Access Lead, Europe & Emerging Markets, Chiesi

Lorenzo Capretto | Market Access Lead, Europe & Emerging Markets | Chiesi » speaking at World EPA Congress

Laurent Carter, Senior Vice President, Head of Global Pricing, Bristol-Myers Squibb

Laurent Carter | Senior Vice President, Head of Global Pricing | Bristol-Myers Squibb » speaking at World EPA Congress

Sandro Cesaro, Head of Europe Market Access & Pricing, AstraZeneca

Sandro Cesaro | Head of Europe Market Access & Pricing | AstraZeneca » speaking at World EPA Congress

Mata Charokopou, Senior Director, Global Head of Access, Pricing & Value, Ucb

Mata Charokopou | Senior Director, Global Head of Access, Pricing & Value | Ucb » speaking at World EPA Congress

Alina Charter, VP Market Access, Pricing and Policy, Alnylam

Alina Charter | VP Market Access, Pricing and Policy | Alnylam » speaking at World EPA Congress

José Luis Sánchez Chorro, Director, Market Access, Spain and Portugal, Jazz Pharmaceuticals

José Luis Sánchez Chorro | Director, Market Access, Spain and Portugal | Jazz Pharmaceuticals » speaking at World EPA Congress

Sally Chung, Vice President, Head of Market Access & Pricing Europe, GSK

Sally Chung | Vice President, Head of Market Access & Pricing Europe | GSK » speaking at World EPA Congress

Paolo Angelo Cortesi, Assistant Professor in Public Health, Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.

Paolo Angelo Cortesi | Assistant Professor in Public Health | Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy. » speaking at World EPA Congress

Elisa Crovato, Director, Pricing & Market Access, Chiesi Group

Elisa Crovato | Director, Pricing & Market Access | Chiesi Group » speaking at World EPA Congress

Matt Cullen, Vice President, Value, Access & Policy, Apellis Pharmaceuticals

Matt Cullen | Vice President, Value, Access & Policy | Apellis Pharmaceuticals » speaking at World EPA Congress

Marcus Dahlman, Head of Market Access Europe, Hansa Biopharma

Marcus Dahlman | Head of Market Access Europe | Hansa Biopharma » speaking at World EPA Congress

Nidhi Dani, Director, Global Market Access, Novartis

Nidhi Dani | Director, Global Market Access | Novartis » speaking at World EPA Congress

Michal Davidescu, Health Access Specialist, Pfizer

Michal Davidescu | Health Access Specialist | Pfizer » speaking at World EPA Congress

Michele de Guise, President and Chief Executive Officer, INESSS

Michele de Guise | President and Chief Executive Officer | INESSS » speaking at World EPA Congress

Rossella Di Bidino, Head of HTA for AI Unit, Graduate School of Health Economics and Management (ALTEMS)

Rossella Di Bidino | Head of HTA for AI Unit | Graduate School of Health Economics and Management (ALTEMS) » speaking at World EPA Congress

Toon Digneffe, Head, Public Affairs & Public Policy, Europe & Canada, Takeda

Toon Digneffe | Head, Public Affairs & Public Policy, Europe & Canada | Takeda » speaking at World EPA Congress

Riad Dirani, Vice President, Global HEOR, Medical Operations & Excellence, Teva Pharmaceuticals

Riad Dirani | Vice President, Global HEOR, Medical Operations & Excellence | Teva Pharmaceuticals » speaking at World EPA Congress

Patricia Dorling, Head, Global HEOR and Real World Evidence, Chiesi Group

Patricia Dorling | Head, Global HEOR and Real World Evidence | Chiesi Group » speaking at World EPA Congress

Dilesh Doshi, Vice President, Global Health Economics and Outcomes Research, Acadia Pharmaceuticals Inc.

Dilesh Doshi | Vice President, Global Health Economics and Outcomes Research | Acadia Pharmaceuticals Inc. » speaking at World EPA Congress

Benjamin Eckert, Senior Vice President, Market Access, Adaptive Biotechnologies

Benjamin Eckert | Senior Vice President, Market Access | Adaptive Biotechnologies » speaking at World EPA Congress

Gina Ewy, VP, Head of Global Market Access, Hansa Biopharma

Gina Ewy | VP, Head of Global Market Access | Hansa Biopharma » speaking at World EPA Congress

Marina Faiella, Director, Forecasting and Business Analytics, BeiGene

Marina Faiella | Director, Forecasting and Business Analytics | BeiGene » speaking at World EPA Congress

Diar Fattah, Director, Health Economics and Outcomes Research, Vertex Pharmaceuticals

Diar Fattah | Director, Health Economics and Outcomes Research | Vertex Pharmaceuticals » speaking at World EPA Congress

Sarah Ferry, Senior Policy Advisor, Innovation & Life Sciences, NHS Confederation

Sarah Ferry | Senior Policy Advisor, Innovation & Life Sciences | NHS Confederation » speaking at World EPA Congress

Stefaan Fiers, Head of Corporate Communication, Public Affairs & Patient Advocacy, Belgium, Takeda

Stefaan Fiers | Head of Corporate Communication, Public Affairs & Patient Advocacy, Belgium | Takeda » speaking at World EPA Congress

Kalitsa Filioussi, Global Director, Early Access, Novartis

Kalitsa Filioussi | Global Director, Early Access | Novartis » speaking at World EPA Congress

Lora Fleifel, Director, Market Access Operations, Oncology Europe, Merck

Lora Fleifel | Director, Market Access Operations, Oncology Europe | Merck » speaking at World EPA Congress

Ishita Gaikwad, Director, Global Integrated Access Strategy, Amgen

Ishita Gaikwad | Director, Global Integrated Access Strategy | Amgen » speaking at World EPA Congress

Benjamin Gannon, Vice President, International, Guardant Health

Benjamin Gannon | Vice President, International | Guardant Health » speaking at World EPA Congress

Fabrizio Gianfrate, Full Professor, Health Economics and Outcomes Research, Former AIFA

Fabrizio Gianfrate | Full Professor, Health Economics and Outcomes Research | Former AIFA » speaking at World EPA Congress

Ramiro Gilardino, Senior Director, Global HTA & Access Policy Lead, MSD

Ramiro Gilardino | Senior Director, Global HTA & Access Policy Lead | MSD » speaking at World EPA Congress

Christoph Glaetzer, Chief Global Value and Access Officer, Janssen

Christoph Glaetzer | Chief Global Value and Access Officer | Janssen » speaking at World EPA Congress

Josie Godfrey, Co-Chief Executive Officer, Realise Advocacy

Josie Godfrey | Co-Chief Executive Officer | Realise Advocacy » speaking at World EPA Congress

Thomas Grub, Senior Expert, Global Pricing and Market Access, medac GmbH

Thomas Grub | Senior Expert, Global Pricing and Market Access | medac GmbH » speaking at World EPA Congress

Josep Maria Guiu Segura, Director, Pharmacy and Medicines Area, Consortium of health and social care of Catalonia

Josep Maria Guiu Segura | Director, Pharmacy and Medicines Area | Consortium of health and social care of Catalonia » speaking at World EPA Congress

Marlene Gyldmark, Vice President, Global Head, HEOR & Epidemiology, Idorsia Pharmaceuticals

Marlene Gyldmark | Vice President, Global Head, HEOR & Epidemiology | Idorsia Pharmaceuticals » speaking at World EPA Congress

Matthew Hanchard, Research Associate, University of Sheffield

Matthew Hanchard | Research Associate | University of Sheffield » speaking at World EPA Congress

Gunter Harms, Senior Director, Patient Access, Germany, Austria, Switzerland, Novartis Gene Therapies

Gunter Harms | Senior Director, Patient Access, Germany, Austria, Switzerland | Novartis Gene Therapies » speaking at World EPA Congress

Adrian Harrington, Senior Director, Value & Access, Biogen

Adrian Harrington | Senior Director, Value & Access | Biogen » speaking at World EPA Congress

Thomas Hasmann, Head of Market Access, Europe, KalVista Pharmaceuticals

Thomas Hasmann | Head of Market Access, Europe | KalVista Pharmaceuticals » speaking at World EPA Congress

Birgit Holz, Global Head, Contracting Innovation, Sanofi

Birgit Holz | Global Head, Contracting Innovation | Sanofi » speaking at World EPA Congress

Alison Horsfield, Director, Global Access Strategy, AstraZeneca

Alison Horsfield | Director, Global Access Strategy | AstraZeneca » speaking at World EPA Congress

Kirsty Hoyle, Chief Executive Officer, Metabolic Support UK

Kirsty Hoyle | Chief Executive Officer | Metabolic Support UK » speaking at World EPA Congress

Giorgio Iotti, Head Of Program Leadership And Control, Rare Disease Unit, Chiesi Farmaceutici SpA

Giorgio Iotti | Head Of Program Leadership And Control, Rare Disease Unit | Chiesi Farmaceutici SpA » speaking at World EPA Congress

Dawn Ireland, President & Founder, CDH International

Dawn Ireland | President & Founder | CDH International » speaking at World EPA Congress

Shrividya Iyer, Independent Expert, RWE and HEOR, Independent Expert

Shrividya Iyer | Independent Expert, RWE and HEOR | Independent Expert » speaking at World EPA Congress

Jayasree Iyer, Chief Executive Officer, Access to Medicine Foundation

Jayasree Iyer | Chief Executive Officer | Access to Medicine Foundation » speaking at World EPA Congress

Saira Jan, Vice-President & Chief Pharmacy Officer, Blue Cross Blue Shield of New Jersey

Saira Jan | Vice-President & Chief Pharmacy Officer | Blue Cross Blue Shield of New Jersey » speaking at World EPA Congress

Mr Pall Jonsson, Programme Director, Data and Real World Evidence, National Institute for Health & Care Excellence (NICE)

Mr Pall Jonsson | Programme Director, Data and Real World Evidence | National Institute for Health & Care Excellence (NICE) » speaking at World EPA Congress

Madhu Kabra, Global Director, Health Economics and Outcomes Research, MKGlobal

Madhu Kabra | Global Director, Health Economics and Outcomes Research | MKGlobal » speaking at World EPA Congress

Lisette Kaskens, Director, Market Access, Europe, LATAM & Canada, Ferring Pharmaceuticals

Lisette Kaskens | Director, Market Access, Europe, LATAM & Canada | Ferring Pharmaceuticals » speaking at World EPA Congress

Sebastian Kessel, Senior Director, Head of Market Access & External Engagement Germany, UCB

Sebastian Kessel | Senior Director, Head of Market Access & External Engagement Germany | UCB » speaking at World EPA Congress

Rob Kettell, Director, Commercial Medicines Negotiation and Complex Transactions, NHS England

Rob Kettell | Director, Commercial Medicines Negotiation and Complex Transactions | NHS England » speaking at World EPA Congress

Elizabeth Kinter, Vice President, Head of Evidence, Value and Access, Vir Biotechnology

Elizabeth Kinter | Vice President, Head of Evidence, Value and Access | Vir Biotechnology » speaking at World EPA Congress

Sandeep Kiri, Global Head, Health Economics and HTA Evidence, Ucb

Sandeep Kiri | Global Head, Health Economics and HTA Evidence | Ucb » speaking at World EPA Congress

Jolanda Koenders, Head of New Product Planning, Central Southeast Europe, Takeda

Jolanda Koenders | Head of New Product Planning, Central Southeast Europe | Takeda » speaking at World EPA Congress

Marianne Laouri, Executive Director, Value Demonstration, Specialty Products & Quality of Care, Boehringer Ingelheim

Marianne Laouri | Executive Director, Value Demonstration, Specialty Products & Quality of Care | Boehringer Ingelheim » speaking at World EPA Congress

Agathe Le Lay, Vice President, Head of Global Value Evidence & Patient Insights, Medical Affairs, H. Lundbeck A/S

Agathe Le Lay | Vice President, Head of Global Value Evidence & Patient Insights, Medical Affairs | H. Lundbeck A/S » speaking at World EPA Congress

Timothy Lenehan, Corporate Vice President, Head of Global Market Access, Novo Nordisk

Timothy Lenehan | Corporate Vice President, Head of Global Market Access | Novo Nordisk » speaking at World EPA Congress

Friedhelm Leverkus, Director, HTA & Outcomes Research, Pfizer

Friedhelm Leverkus | Director, HTA & Outcomes Research | Pfizer » speaking at World EPA Congress

Penny Lovell, Head of Access, Pricing and External Engagement, Ucb

Penny Lovell | Head of Access, Pricing and External Engagement | Ucb » speaking at World EPA Congress

Katja Lundell, Senior Director, Global Head of Pricing, Access and Communications, theramex

Katja Lundell | Senior Director, Global Head of Pricing, Access and Communications | theramex » speaking at World EPA Congress

Elena Lungu, Manager of Policy Development, Patented Medicine Prices Review Board, Government of Canada

Elena Lungu | Manager of Policy Development, Patented Medicine Prices Review Board | Government of Canada » speaking at World EPA Congress

Jörg Mahlich, Market Access and Government Affairs Lead, Miltenyi

Jörg Mahlich | Market Access and Government Affairs Lead | Miltenyi » speaking at World EPA Congress

Charles Makin, Global Head, Health Economics and Outcomes Research, HTA & Real-World Evidence, Biogen

Charles Makin | Global Head, Health Economics and Outcomes Research, HTA & Real-World Evidence | Biogen » speaking at World EPA Congress

Shabana Malik, Director, Access, UK & Ireland, BIOMERIEUX

Shabana Malik | Director, Access, UK & Ireland | BIOMERIEUX » speaking at World EPA Congress

Farzana Malik, Independent Market Access Expert

Farzana Malik |  | Independent Market Access Expert » speaking at World EPA Congress

Chris Mancill, Senior Vice President & Head, Worldwide Value Access, Payment and HEOR, Bristol Myers Squibb

Chris Mancill | Senior Vice President & Head, Worldwide Value Access, Payment and HEOR | Bristol Myers Squibb » speaking at World EPA Congress

Lorenzo Mantovani, Professor of Public Health, University Of Milano - Bicocca

Lorenzo Mantovani | Professor of Public Health | University Of Milano - Bicocca » speaking at World EPA Congress

Marco Marchetti, Co-Chair, HTA Coordination Group & Director, Health Technology Assessment Unit, European Commission & National Agency for Regional Care Services, Italy

Marco Marchetti | Co-Chair, HTA Coordination Group & Director, Health Technology Assessment Unit | European Commission & National Agency for Regional Care Services, Italy » speaking at World EPA Congress

Silvy Mardiguian, Senior Director, Head of HEOR, Europe & New Markets, BeiGene

Silvy Mardiguian | Senior Director, Head of HEOR, Europe & New Markets | BeiGene » speaking at World EPA Congress

Francesco Marinucci, Director, Global Market Access, Abbott

Francesco Marinucci | Director, Global Market Access | Abbott » speaking at World EPA Congress

Jake McDowell, Vice President, Head of Market Access and Pricing, Partner Therapeutics

Jake McDowell | Vice President, Head of Market Access and Pricing | Partner Therapeutics » speaking at World EPA Congress

Sean McElligott, Executive Director, Head, US Health Economics Outcomes Research, Novartis

Sean McElligott | Executive Director, Head, US Health Economics Outcomes Research | Novartis » speaking at World EPA Congress

Erin Mistry, Executive Vice President, Chief Commercial Officer, CorMedix Inc

Erin Mistry | Executive Vice President, Chief Commercial Officer | CorMedix Inc » speaking at World EPA Congress

Lorenzo Montrasio, Senior Scientific Officer, Council of Europe

Lorenzo Montrasio | Senior Scientific Officer | Council of Europe » speaking at World EPA Congress

Paolo Morgese, Head of Public Affairs, Europe, Alliance for Regenerative Medicine

Paolo Morgese | Head of Public Affairs, Europe | Alliance for Regenerative Medicine » speaking at World EPA Congress

Tal Morginstin, Director, HTA division, Ministry of Health, Israel

Tal Morginstin | Director, HTA division | Ministry of Health, Israel » speaking at World EPA Congress

Christine Mossa, Senior Director, Regulatory Affairs, Public Affairs, Value & Access, Ipsen Biopharmaceuticals Canada Inc.

Christine Mossa | Senior Director, Regulatory Affairs, Public Affairs, Value & Access | Ipsen Biopharmaceuticals Canada Inc. » speaking at World EPA Congress

Michael Mueller, Head Of Market Access, Western Europe, Sun pharma

Michael Mueller | Head Of Market Access, Western Europe | Sun pharma » speaking at World EPA Congress

Neil Mulcock, Vice President, International Government Affairs and Policy, Gilead Sciences

Neil Mulcock | Vice President, International Government Affairs and Policy | Gilead Sciences » speaking at World EPA Congress

Bogdan Muresan, Director, Global HEOR, Astellas Pharma

Bogdan Muresan | Director, Global HEOR | Astellas Pharma » speaking at World EPA Congress

Alexander Natz, Director General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Alexander Natz | Director General | EUCOPE - European Confederation of Pharmaceutical Entrepreneurs » speaking at World EPA Congress

Claudia Neuber, Head of Global Pricing, Oncology, AstraZeneca

Claudia Neuber | Head of Global Pricing, Oncology | AstraZeneca » speaking at World EPA Congress

Enkeleida Nikai-Fitzgerald, Vice President, Head of Global Real-World Evidence, GenMed, Sanofi

Enkeleida Nikai-Fitzgerald | Vice President, Head of Global Real-World Evidence, GenMed | Sanofi » speaking at World EPA Congress

Eric Noehrenberg, Global Vice President, Market Access and Government Affairs, CORCYM

Eric Noehrenberg | Global Vice President, Market Access and Government Affairs | CORCYM » speaking at World EPA Congress

Andrew Olaye, Executive Director, Head of Market Access and Partnership EMEA, Orchard Therapeutics Ltd

Andrew Olaye | Executive Director, Head of Market Access and Partnership EMEA | Orchard Therapeutics Ltd » speaking at World EPA Congress

Lucinda Orsini, Vice President, Value and Outcomes Research, COMPASS Pathways

Lucinda Orsini | Vice President, Value and Outcomes Research | COMPASS Pathways » speaking at World EPA Congress

Donal O'Sullivan, Vice President, Head of Pricing & Tenders, CSL Vifor

Donal O'Sullivan | Vice President, Head of Pricing & Tenders | CSL Vifor » speaking at World EPA Congress

Ipek Ozer-Stillman, Vice President, Global Head, Health Economics, Takeda

Ipek Ozer-Stillman | Vice President, Global Head, Health Economics | Takeda » speaking at World EPA Congress

Elena Panitti, Global Director, Evidence Valuation and Enablement, Novartis

Elena Panitti | Global Director, Evidence Valuation and Enablement | Novartis » speaking at World EPA Congress

Michela Pantaleoni, Chief Market Access Officer, Napo Therapeutics

Michela Pantaleoni | Chief Market Access Officer | Napo Therapeutics » speaking at World EPA Congress

Dilip Patel, VP Market Access, Autolus

Dilip Patel | VP Market Access | Autolus » speaking at World EPA Congress

Julien Patris, Head of Patient Advocacy and Public Policy, EMEA, arGEN-X

Julien Patris | Head of Patient Advocacy and Public Policy, EMEA | arGEN-X » speaking at World EPA Congress

Marco Penske, Head, Market Access & Healthcare Affairs, Germany, Boehringer-Ingelheim

Marco Penske | Head, Market Access & Healthcare Affairs, Germany | Boehringer-Ingelheim » speaking at World EPA Congress

Diogo Teixeira Pereira, Affiliate Member of NOVA SBE, Health Economics & Management Knowledge Center, Universidade NOVA de Lisboa

Diogo Teixeira Pereira | Affiliate Member of NOVA SBE, Health Economics & Management Knowledge Center | Universidade NOVA de Lisboa » speaking at World EPA Congress

Tomaso Piaggio, Director, Head of Southern Cluster, International Market Access, Alnylam Pharmaceuticals

Tomaso Piaggio | Director, Head of Southern Cluster, International Market Access | Alnylam Pharmaceuticals » speaking at World EPA Congress

Andres Pichon Riviere, Executive Director, Health Technology Assessment And Economic Evaluations, I.E.C.S.

Andres Pichon Riviere | Executive Director, Health Technology Assessment And Economic Evaluations | I.E.C.S. » speaking at World EPA Congress

Trine Pilgaard, Director, Head of Market Access, Denmark and Iceland, Pfizer

Trine Pilgaard | Director, Head of Market Access, Denmark and Iceland | Pfizer » speaking at World EPA Congress

Carme Pinyol, Early Products and HEOR Lead, Novartis

Carme Pinyol | Early Products and HEOR Lead | Novartis » speaking at World EPA Congress

Lara Pippo, Head Of Market Access & Government Affairs, Italy, CSL Behring

Lara Pippo | Head Of Market Access & Government Affairs, Italy | CSL Behring » speaking at World EPA Congress

Jonathan Plumb, Vice President, Head, Global Value & Access, Ferring Pharmaceuticals SA

Jonathan Plumb | Vice President, Head, Global Value & Access | Ferring Pharmaceuticals SA » speaking at World EPA Congress

Tanja Podkonjak, Director, Access and Reimbursement Policy, Oncology, EUCAN, Takeda

Tanja Podkonjak | Director, Access and Reimbursement Policy, Oncology, EUCAN | Takeda » speaking at World EPA Congress

Mary Lynne Van Poelgeest-Pomfret, President, World Federation For Incontinent Patients

Mary Lynne Van Poelgeest-Pomfret | President | World Federation For Incontinent Patients » speaking at World EPA Congress

Mr Luca Luigi Polastri, Global Director, Payor Value and Patient Access Head, Kyowa Kirin

Mr Luca Luigi Polastri | Global Director, Payor Value and Patient Access Head | Kyowa Kirin » speaking at World EPA Congress

Daniella Rahamim-Cohen, Director, Community Medicine, Maccabi Healthcare Services

Daniella Rahamim-Cohen | Director, Community Medicine | Maccabi Healthcare Services » speaking at World EPA Congress

Marco Rauland, Vice President, Global Head of GVAP Strategic Planning & Data Science, Global Evidence Demonstration, Market Access and Pricing, Merck Group

Marco Rauland | Vice President, Global Head of GVAP Strategic Planning & Data Science, Global Evidence Demonstration, Market Access and Pricing | Merck Group » speaking at World EPA Congress

Laurene Redding, Global Head, Value, Access & Pricing, ex-China, BeiGene

Laurene Redding | Global Head, Value, Access & Pricing, ex-China | BeiGene » speaking at World EPA Congress

Juan Carlos Rejon-Parrilla, Senior HTA and Health Policy Researcher, Andalusian Regional Department of Health

Juan Carlos Rejon-Parrilla | Senior HTA and Health Policy Researcher | Andalusian Regional Department of Health » speaking at World EPA Congress

Rogerio Ribeiro, Senior Vice President, Head of Global Commercial, Vaccines Business Unit, Takeda

Rogerio Ribeiro | Senior Vice President, Head of Global Commercial, Vaccines Business Unit | Takeda » speaking at World EPA Congress

Andre Roeder, Head, Global Market Access, TETEC AG

Andre Roeder | Head, Global Market Access | TETEC AG » speaking at World EPA Congress

Alexander Roediger, Associate Vice President, Global Lead, Oncology Policy, MSD

Alexander Roediger | Associate Vice President, Global Lead, Oncology Policy | MSD » speaking at World EPA Congress

Ivanna Rosendal, Senior Director, Head of Commercial and Medical IT, Ascendis Pharma A/S

Ivanna Rosendal | Senior Director, Head of Commercial and Medical IT | Ascendis Pharma A/S » speaking at World EPA Congress

Shaun Rowark, Associate Director, Data Access and Analysis, NICE

Shaun Rowark | Associate Director, Data Access and Analysis | NICE » speaking at World EPA Congress

Igor Rudychev, Vice President, Enterprise Analytics, Horizon Therapeutics

Igor Rudychev | Vice President, Enterprise Analytics | Horizon Therapeutics » speaking at World EPA Congress

Sandrine Ruiz, Senior Director, Market Access, Pricing & HEOR, Immunocore Ltd

Sandrine Ruiz | Senior Director, Market Access, Pricing & HEOR | Immunocore Ltd » speaking at World EPA Congress

Erik Sagdahl, Head of Procurement, Pharmaceutical Division, Sykehusinnkjop

Erik Sagdahl | Head of Procurement, Pharmaceutical Division | Sykehusinnkjop » speaking at World EPA Congress

Peter Sajosi, Director, Regional Value and Access Lead, Amgen

Peter Sajosi | Director, Regional Value and Access Lead | Amgen » speaking at World EPA Congress

Jose Luis Sanchez Chorro, Director, Market Access, Spain and Portugal, Jazz Pharmaceuticals

Jose Luis Sanchez Chorro | Director, Market Access, Spain and Portugal | Jazz Pharmaceuticals » speaking at World EPA Congress

Steve Sandor, Vice President, Market Access, Government Affairs and Trade, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President, Market Access, Government Affairs and Trade | Paratek Pharmaceuticals , Inc. » speaking at World EPA Congress

Eduardo Santos, Executive Director, Therapeutic Area Head, General Medicines, Global Value, Access & Pricing, Amgen

Eduardo Santos | Executive Director, Therapeutic Area Head, General Medicines, Global Value, Access & Pricing | Amgen » speaking at World EPA Congress

Michael Schlander, Head of Division of Health Economics & Professor of Health Economics, German Cancer Research Center & University of Heidelberg

Michael Schlander | Head of Division of Health Economics & Professor of Health Economics | German Cancer Research Center & University of Heidelberg » speaking at World EPA Congress

Fabian Schmidt, Head of Market Access / HEOR, Recordati Rare Diseases Sarl

Fabian Schmidt | Head of Market Access / HEOR | Recordati Rare Diseases Sarl » speaking at World EPA Congress

Ayman Semaan, Market Access & Pricing Lead, Biologix

Ayman Semaan | Market Access & Pricing Lead | Biologix » speaking at World EPA Congress

Shuvayu Sen, Vice President and Head of Oncology, Center of Observational & Real World Evidence, MERCK

Shuvayu Sen | Vice President and Head of Oncology, Center of Observational & Real World Evidence | MERCK » speaking at World EPA Congress

Hans Severens, Independent HTA Expert, Former Vice President,, Dutch Health Council

Hans Severens | Independent HTA Expert, Former Vice President, | Dutch Health Council » speaking at World EPA Congress

Kun Shi-van Wielink, EMEA Associate Director, HEOR/RWE Market Access, Santen

Kun Shi-van Wielink | EMEA Associate Director, HEOR/RWE Market Access | Santen » speaking at World EPA Congress

Simon Shohet, Vice President, Market Access, International, Amicus Therapeutics

Simon Shohet | Vice President, Market Access, International | Amicus Therapeutics » speaking at World EPA Congress

Rita Shorjian, Commercial Director, Determatology, Intercontinental, Middle East, Africa and Russia, Abbvie

Rita Shorjian | Commercial Director, Determatology, Intercontinental, Middle East, Africa and Russia | Abbvie » speaking at World EPA Congress

Matt Slabbert, Vice President, Global Head of Pharma Public Affairs, Bayer

Matt Slabbert | Vice President, Global Head of Pharma Public Affairs | Bayer » speaking at World EPA Congress

Paul Slobbe, Director, Access and External Affairs, Takeda Nederland B.V.

Paul Slobbe | Director, Access and External Affairs | Takeda Nederland B.V. » speaking at World EPA Congress

Jiri Smejkal, Global Head of Pricing and Tender Excellence for PDT, Takeda

Jiri Smejkal | Global Head of Pricing and Tender Excellence for PDT | Takeda » speaking at World EPA Congress

Igor Solev, Global Head of Market Access, Policy & External Payer Affairs, Abbott Laboratories

Igor Solev | Global Head of Market Access, Policy & External Payer Affairs | Abbott Laboratories » speaking at World EPA Congress

Seema Sondhi, Vice President, Head of Global Strategic Projects, Takeda

Seema Sondhi | Vice President, Head of Global Strategic Projects | Takeda » speaking at World EPA Congress

Rafael Souza, Director, Access Solutions & Pricing, New Markets, BeiGene

Rafael Souza | Director, Access Solutions & Pricing, New Markets | BeiGene » speaking at World EPA Congress

Ulf Staginnus, Vice President, International Market Access & Pricing, Blueprint Medicines

Ulf Staginnus | Vice President, International Market Access & Pricing | Blueprint Medicines » speaking at World EPA Congress

Kim Stephens, Executive Director, Muenzer MPS Research & Treatment Center

Kim Stephens | Executive Director | Muenzer MPS Research & Treatment Center » speaking at World EPA Congress

Helen Stoop, Senior Director, Head of Patient Advocacy, Europe & Canada, Takeda

Helen Stoop | Senior Director, Head of Patient Advocacy, Europe & Canada | Takeda » speaking at World EPA Congress

Pernille Storm, Vice President, Global Pricing and Market Access, Lundbeck

Pernille Storm | Vice President, Global Pricing and Market Access | Lundbeck » speaking at World EPA Congress

Rachel Studer, Global Executive Director Launch Evidence, Novartis

Rachel Studer | Global Executive Director Launch Evidence | Novartis » speaking at World EPA Congress

Teddy Sun, Evidence Generation Lead, Nordic Data Digital & Technology (DDT), Takeda

Teddy Sun | Evidence Generation Lead, Nordic Data Digital & Technology (DDT) | Takeda » speaking at World EPA Congress

Annie Syntosi, Global Associate Director, Value & Access, HEOR, Global Health,, Novartis Pharma AG

Annie Syntosi | Global Associate Director, Value & Access, HEOR, Global Health, | Novartis Pharma AG » speaking at World EPA Congress

Monika Szkultecka-Debek, Vice President, Qualitas Vitae Institute Foundation

Monika Szkultecka-Debek | Vice President | Qualitas Vitae Institute Foundation » speaking at World EPA Congress

Neeta Tandon, Vice President, Value & Evidence Scientific Engagement, Janssen

Neeta Tandon | Vice President, Value & Evidence Scientific Engagement | Janssen » speaking at World EPA Congress

Tina Taube, Director, Market Access and Orphan Drug Policy Lead, EFPIA

Tina Taube | Director, Market Access and Orphan Drug Policy Lead | EFPIA » speaking at World EPA Congress

Sheena Thakkar, Director, Value & Evidence, Pfizer

Sheena Thakkar | Director, Value & Evidence | Pfizer » speaking at World EPA Congress

Luca Tofani, Director, Pricing and Reimbursement, S.I.F.I. Spa

Luca Tofani | Director, Pricing and Reimbursement | S.I.F.I. Spa » speaking at World EPA Congress

Ariella Toren, Director, Medicine and Medical Technologies, HMOS Department, Ministry of Health, Israel

Ariella Toren | Director, Medicine and Medical Technologies, HMOS Department | Ministry of Health, Israel » speaking at World EPA Congress

Kaan Tunceli, Vice President and Head, Global Value and Real World Evidence, Otsuka Pharmaceutical

Kaan Tunceli | Vice President and Head, Global Value and Real World Evidence | Otsuka Pharmaceutical » speaking at World EPA Congress

Allister Upton, Director, Market Access and Business Development, EMEA, Alimera Sciences Ltd

Allister Upton | Director, Market Access and Business Development, EMEA | Alimera Sciences Ltd » speaking at World EPA Congress

Bart Van Den Daele, Director, Market Access, Head of External Affairs, Gilead Sciences

Bart Van Den Daele | Director, Market Access, Head of External Affairs | Gilead Sciences » speaking at World EPA Congress

Goedele van Haasteren, Deputy chief Section HTA, Federal Office of Public Health, Switzerland

Goedele van Haasteren | Deputy chief Section HTA | Federal Office of Public Health, Switzerland » speaking at World EPA Congress

Chantal van Litsenburg, Manager, Translational Effectiveness, Leiden University Medical Center (Netherlands)

Chantal van Litsenburg | Manager, Translational Effectiveness | Leiden University Medical Center (Netherlands) » speaking at World EPA Congress

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Medical Advisor, National Evaluation Committee for Specialised Medicine, CZ

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani | Medical Advisor, National Evaluation Committee for Specialised Medicine | CZ » speaking at World EPA Congress

Christina Vandorou, Director, Macroeconomics And Health Policy, EMEA, Janssen

Christina Vandorou | Director, Macroeconomics And Health Policy, EMEA | Janssen » speaking at World EPA Congress

Kärt Veliste, Service Manager, Department of Medicines and Medical Devices, Tervisekassa Estonian Health Insurance Fund

Kärt Veliste | Service Manager, Department of Medicines and Medical Devices | Tervisekassa Estonian Health Insurance Fund » speaking at World EPA Congress

Juliette Vila Sinclair/Spence, Rare Disease Patient Advocate & Chairwoman, Acanthamoeba Keratitis Eye Foundation

Juliette Vila Sinclair/Spence | Rare Disease Patient Advocate & Chairwoman | Acanthamoeba Keratitis Eye Foundation » speaking at World EPA Congress

Keith White, Head, Global Market Access, Amylyx Pharmaceuticals

Keith White | Head, Global Market Access | Amylyx Pharmaceuticals » speaking at World EPA Congress

Kalman Emry Wijaya, Director, Head of Pricing, Tender and Contracting, Biogen

Kalman Emry Wijaya | Director, Head of Pricing, Tender and Contracting | Biogen » speaking at World EPA Congress

Rhys Williams, Vice President, Evidence Generation Strategy and Health Economics, Global Medical Affairs (ex-China), BeiGene

Rhys Williams | Vice President, Evidence Generation Strategy and Health Economics, Global Medical Affairs (ex-China) | BeiGene » speaking at World EPA Congress

Durhane Wong-Rieger, President, Chief Executive Officer & Chair, Canadian Organisation for Rare Diseases & Rare Diseases International

Durhane Wong-Rieger | President, Chief Executive Officer & Chair | Canadian Organisation for Rare Diseases & Rare Diseases International » speaking at World EPA Congress

Mr Keir Woods, Vice President, Head of Global Market Access and Pricing, Merck Group

Mr Keir Woods | Vice President, Head of Global Market Access and Pricing | Merck Group » speaking at World EPA Congress

Lori Yin, Associate Director, Access Lead, Roche

Lori Yin | Associate Director, Access Lead | Roche » speaking at World EPA Congress

Zinajda Zolic-Karlsson, Senior advisor HTA, Norwegian Medicines Agency

Zinajda Zolic-Karlsson | Senior advisor HTA | Norwegian Medicines Agency » speaking at World EPA Congress

Get Involved 
 

Sponsorship & Exhibition Sales


David Boore 
david.boore@terrapinn.com
+44 20 8164 3052

Conference Production


George Mullens
george.mullens@terrapinn.com
+44 20 8164 3940

Marketing Opportunities


Diana Cobzac
diana.cobzac@terrapinn.com